Insulet Corp: Form 10-Q for the period ended Sep 30, 2012
Filed with the SEC on Nov 8, 2012 and accepted by EDGAR at Nov 8, 2012, 22:16 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2012-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2012-07-01 to 2012-09-30 | $54.8m | us-gaap:SalesRevenueNet |
| Revenue | 9 months2012-01-01 to 2012-09-30 | $153.5m | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months2012-07-01 to 2012-09-30 | $30.4m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2012-01-01 to 2012-09-30 | $86.5m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2012-07-01 to 2012-09-30 | $24.4m | us-gaap:GrossProfit |
| Gross profit | 9 months2012-01-01 to 2012-09-30 | $67.0m | us-gaap:GrossProfit |
| Research and development | 3 months2012-07-01 to 2012-09-30 | $6.6m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2012-01-01 to 2012-09-30 | $18.5m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2012-07-01 to 2012-09-30 | −$8.5m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2012-01-01 to 2012-09-30 | −$29.9m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2012-07-01 to 2012-09-30 | $28.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2012-01-01 to 2012-09-30 | $143.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2012-07-01 to 2012-09-30 | −$12.4m | us-gaap:NetIncomeLoss |
| Net income | 9 months2012-01-01 to 2012-09-30 | −$41.7m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2012-07-01 to 2012-09-30 | −$0.26 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 9 months2012-01-01 to 2012-09-30 | −$0.87 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 9 months2012-01-01 to 2012-09-30 | −$23.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2012-01-01 to 2012-09-30 | $8.9m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2012-09-30 | $63.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2012-09-30 | $113.4m | us-gaap:AssetsCurrent |
| Total assets | At period end2012-09-30 | $191.6m | us-gaap:Assets |
| Current liabilities | At period end2012-09-30 | $49.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2012-09-30 | $152.5m | us-gaap:Liabilities |
| Long-term debt | At period end2012-09-30 | $101.5m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2012-09-30 | $14.1m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2012-09-30 | $39.1m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001193125-12-460797. Last ingested by Listed: Nov 4, 2026, 16:38 ET. Listed shows no prices and gives no investment advice.